Scott M. Whitcup

Filings by Scott M. Whitcup span 4 companies, the busiest being Allergan Inc, Avanir Pharmaceuticals and Questcor Pharmaceuticals Inc. Over a trading history stretching from 6 February 2006 to 7 June 2019, the count stands at 111 filings.

Every open-market trade on record is a sale: 39 sales worth €29.0M. Other entries cover 29 share grants and 36 option exercises.

The latest filing, published on 7 June 2019, reports a transaction of €1.7M in Nightstar Therapeutics plc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.